Contact us

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Building Prevention

We quantify the spine in routine computed tomography.
Contact us
Request a demo

OUR STORY

Bonescreen offers a novel, AI-based technology for non-invasive extraction of biomarkers from existing medical images to assist radiologists and clinicians in evaluating bone health.

products

SpineQ® assists
clinicians*

SpineQ® assists clinicians in diagnosing osteoporosis from almost any existing routine CT containing the spine. SpineQ® provides a comprehensive spine report, including a level-wise annotation, a calibrated, reproducible bone mineral density measurement and osteoporotic fracture identification. It is designed to improve report quality by highlighting abnormal findings relevant for osteoporosis that are frequently overlooked.
Request a demo

products

SpineR facilitates
your spine
processing*

SpineR is easily integrated as the backbone of spine processing. In CT scans, SpineR segments and labels all vertebrae, identifies subregions and special points of interest. This is commonly needed in automated surgery planning, PACS overlays, finite element modelling, 3D printing and more. SpineR outperforms current state-of-the-art methods for spine segmentation in a computationally efficient way. SpineR readily identifies transitional vertebrae and all enumeration anomalies.
Request a demo

Products

SpineQ® assists clinicians*

SpineQ® assists clinicians in diagnosing osteoporosis from almost any existing routine CT containing the spine. SpineQ® provides a comprehensive spine report, including a level-wise annotation, a calibrated, reproducible bone mineral density measurement and osteoporotic fracture identification. It is designed to improve report quality by highlighting abnormal findings relevant for osteoporosis that are frequently overlooked.

Request a demo

SpineR facilitates your spine processing*

SpineR is easily integrated in many environments as the backbone of spine processing. In CT scans, SpineR segments and labels all vertebrae, identifies subregions and special points of interest, as commonly needed in automated surgery planning, PACS overlays, finite element modelling, 3D printing and more. SpineR outperforms current state-of-the-art methods for spine segmentation in a computationally efficient way without the need for a GPU. SpineR readily identifies transitional vertebrae and all enumeration anomalies.

Request a demo

users

SpineQ® fits your needs

Optimised for your working environment

Research
Enabling bone researchers with advanced tools for precise segmentation and landmark detection, accelerating their research efforts.
PACS
Seamlessly integrating context information and anatomical guidance, enhancing the efficiency and completeness of patient records.
Spine Surgery
Intraoperative provision of level-specific quantitative information on bone quality to surgeons in real time.
Clinicians
Providing clinicians with a quick, at-a-glance way to identify patients 
at risk, enhancing patient care and decision-making.
Radiologists
Empowering radiologists with precise, quantitative insights into bone diseases, such as osteoporosis, for more informed diagnoses.

Radiologists

Empowering radiologists with precise, quantitative insights into bone diseases, such as osteoporosis, for more informed diagnoses.

PACS

Seamlessly integrating context information and anatomical guidance, enhancing the efficiency and completeness of patient records.

Research

Enabling bone researchers with advanced tools for precise segmentation and landmark detection, accelerating their research efforts.

Clinicians

Providing clinicians with a quick, at-a-glance way to identify patients
at risk, enhancing patient care and decision-making.

Spine Surgery

Intraoperative provision of level-specific quantitative information on bone quality to surgeons in real time.

about us

Bonescreen was founded in 2022 and is headquartered in Munich.

Bonescreen consists of a team rich in experience and diverse in background, be it physics, computer science, medicine, radiology, medical technology or business and finance

Collectively, we have 25 years of experience in radiology and 15 of experience in software engineering and machine learning.
Anjany began his career as a software engineer and went on to earn a PhD in computer science, with one clear goal: teaching machines to understand medical images. Today he works at the interface of technology and medicine, making sure our developers and doctors speak the same language.
Anjany
CEO
Malek is a biomedical professional with a background in software development and deep learning for medical
imaging. Malek ensures that our product meets customer,
regulatory, and quality
requirements.
Malek
CTO
Giles is a biomedical engineer with special interest and experience in deep learning. He ensures the smooth running of Bonescreen's IT infrastructure and puts together the nuts and bolts of the products.
Giles
CPO
Sebastian is a medical doctor specialising in neuroradiology. He is passionate about continuously improving data-driven healthcare technologies to deliver outcomes that really matter to patients.
Sebastian
CMO
Dominik splits his time between funding and business development. Prior to joining as CFO, he worked for J.P. Morgan in Sweden and the UK. If you want to get him excited outside of work, ask him about his Italian wine collection.
Dominik
CFO
Jan is Professor and Director of Neuroradiology at the Technical University of Munich (TUM). As an expert in osteoporosis and computational imaging, he ensures our technology delivers real value for patient care.
Jan
Clinical Strategy Lead
Anjany began his career as a software engineer and went on to earn a PhD in computer science, with one clear goal: teaching machines to understand medical images. Today he works at the interface of technology and medicine, making sure our developers and doctors speak the same language.
Anjany
CEO
Badiaa holds a Master's degree from the Polytechnic University of Turin and has extensive experience in machine learning and data science. She focuses on building robust, reproducible algorithms and driving their deployment and monitoring in production.
Badiaa
Lead ML Engineer
Malek is a biomedical professional with a background in software development and deep learning for medical imaging. Malek ensures that our product meets customer, regulatory, and quality requirements.
Malek
CTO
Giles is a biomedical engineer with special interest and experience in deep learning. He ensures the smooth running of Bonescreen's IT infrastructure and puts together the nuts and bolts of the products.
Giles
CPO
Sebastian is a medical doctor specialising in neuroradiology. He is passionate about continuously improving data-driven healthcare technologies to deliver outcomes that really matter to patients.
Sebastian
CMO
Dominik splits his time between funding and business development. Prior to joining as CFO, he worked for J.P. Morgan in Sweden and the UK. If you want to get him excited outside of work, ask him about his Italian wine collection.
Dominik
CFO
Svenja holds a Master's degree in Molecular Biotechnology from the Technical University of Munich with a focus on cancer research. She is passionate about putting scientific findings into practice. At Bonescreen, she is mainly responsible for quality management and research.
Svenja
Regulatory Affairs
Jan is Professor and Director of Neuroradiology at the Technical University of Munich (TUM). As an expert in osteoporosis and computational imaging, he ensures our technology delivers real value for patient care.
Jan
Clinical Strategy Lead

Why do we need
biomarker extraction?

The doubling of the population older than 60 years during the next three decades will bring an explosion of bone-health-related conditions. Among these, osteoporosis represents the most common bone disease in humans.

EFFECTIVE SCREENING

Osteoporosis is a disease that can be treated effectively if diagnosed early. However, effective screening programmes are currently missing. This is what Bonescreen aims to improve with our AI-based opportunistic screening software.

Preventive healthcare remains an underserved market

On average, European countries invest around 3–4% of their total healthcare spend in preventive measures. The remaining 97% of costs go to treating diseases.

REDUCED COST

This is too low, claims the OECD. Estimates imply that healthcare costs could be reduced by 30% if more preventive action were taken. In light of the €55bn the EU spends every year on the treatment of osteoporotic fractures, this implies cost savings of €15bn.
‍
PREVENTION

Not to mention the loss of quality of life for the more than 4 million European patients who suffer an osteoporotic fracture each year. At Bonescreen, we build prevention: a tool that gives millions of Europeans access to preventive measures.

Our Aim

is to prevent fractures and make dignified ageing possible: Bonescreen will increase screening rates for osteoporosis by utilising existing medical imaging data. With this, Bonescreen contributes to a prevention-based healthcare system away from primarily treating complications [Löffler MT et al., Eur Radiol. 2021; Sollmann N et al., J Bone Miner Res. 2022].

33%

of women and 20% of men older than 50 years will have an osteoporotic fracture during their lifetime. In Europe, osteoporotic fractures are the fourth leading cause of morbidity, after ischaemic heart disease, dementia and lung cancer, but ahead of chronic obstructive pulmonary disease and ischaemic stroke.

91%

of patients who should be treated according to current osteoporosis guidelines do NOT receive their appropriate treatment in Germany, with similar figures across Europe. This huge treatment gap is mainly caused by a diagnostic gap, which in turn is due to a lack of appropriate screening strategies [McCloskey E et al., Osteoporos Int 2021].

€55bn+

were spent in Europe to treat osteoporosis-related fragility fractures in 2019. Only €1.7bn were spent on medication that can prevent subsequent fractures. These numbers don’t account for additional personal and societal costs due to pain, reduced mobility, disability, lost working days and increased mortality [Kanis JA et al., Arch Osteoporos. 2021].

81%

specificity was observed for opportunistic quantitative CT to predict vertebral fractures during follow-up in a study by Löffler et al. The overall diagnostic performance, measured as the area under the curve (AUC), significantly outperformed dual X-ray absorptiometry (DXA) in multiple studies [Chalhoub D et al., Bone 2016; Löffler MT et al., Eur Radiol. 2019].

97%

Despite widely available and effective treatment options, more than 97% of osteoporosis-related health care costs are spent on treating fractures and only less than 3% on prevention. As osteoporosis is well treatable in early stages, many medical societies advocate a population-based screening programme based on bone density measurements.

12%

of humans have anomalies at the spine, where additional lumbar vertebrae are the most frequent ones among Europeans, while thoracolumbar transitional vertebrae dominate in Asia. Our fully automated labelling and segmentation readily and reliably identifies those anomalies and is consistent with functional nerve anatomy [Ishiguro K et al. Sci Rep 2020].

Try today*

Request a demo
*SpineQ® is a CE-marked medical device. SpineR was not developed as a medical device; it is intended for research use only.
to top of page